{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:17:27Z","timestamp":1793146647531,"version":"4.5.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T00:00:00Z","timestamp":1331510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033029","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T21:22:13Z","timestamp":1331587333000},"page":"e33029","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":73,"title":["Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan"],"prefix":"10.1371","volume":"7","author":[{"given":"Masanori","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayami","family":"Isonishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura:report of 16 cases and review of the literature.","volume":"45","author":"EL Amorosi","year":"1966","journal-title":"Medicine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.","volume":"339","author":"M Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.","volume":"339","author":"HM Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.","volume":"413","author":"GG Levy","year":"2001","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood-2003-05-1616","article-title":"Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.","volume":"102","author":"F Scheiflinger","year":"2003","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood-2006-02-006064","article-title":"Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity.","volume":"109","author":"S Ferrari","year":"2007","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.","volume":"102","author":"SK Vesely","year":"2003","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.","volume":"103","author":"XL Zheng","year":"2004","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.md.0000133622.03370.07","article-title":"Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement.","volume":"83","author":"P Coppo","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura.","volume":"115","author":"JA Kremer-Hovinga","year":"2010","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.","volume":"98","author":"A Veyradier","year":"2001","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features.","volume":"142","author":"M Scully","year":"2008","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12185-011-0771-5","article-title":"Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience.","volume":"93","author":"MJ Jang","year":"2011","journal-title":"Int J Hematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2141.2005.05857.x","article-title":"Thrombotic thrombocytopenic purpura\/haemolytic uraemic syndrome: a new index predicting response to plasma exchange.","volume":"132","author":"BF Wyllie","year":"2006","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-8652(200011)65:3<251::AID-AJH13>3.0.CO;2-2","article-title":"High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura.","volume":"65","author":"HM Tsai","year":"2000","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2005.05512.x","article-title":"The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.","volume":"129","author":"M Bohm","year":"2005","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998\u20132008.","volume":"49","author":"Y Fujimura","year":"2009","journal-title":"Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.","volume":"87","author":"M Furlan","year":"1996","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02982558","article-title":"Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.","volume":"74","author":"S Kinoshita","year":"2001","journal-title":"Int J Hematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.","volume":"46","author":"S Kato","year":"2006","journal-title":"Transfusion"},{"key":"ref21","first-page":"612","article-title":"Proceedings: A more uniform measurement of factor VIII inhibitors.","volume":"34","author":"CK Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T03:10:22Z","timestamp":1593832222000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033029"}},"subtitle":[],"editor":[{"given":"Pieter H.","family":"Reitsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,12]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033029","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,12]]}}}